scholarly article | Q13442814 |
P356 | DOI | 10.1093/INFDIS/122.3.170 |
P953 | full work available at URL | http://academic.oup.com/jid/article-pdf/122/3/170/3052388/122-3-170.pdf |
P698 | PubMed publication ID | 4915510 |
P50 | author | Armando Caceres | Q68149947 |
Leonardo J. Mata | Q109797136 | ||
P2093 | author name string | E. J. Gangarosa | |
M. L. Mejicanos | |||
D. R. Perera | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Guatemala | Q774 |
epidemic | Q44512 | ||
P304 | page(s) | 170-180 | |
P577 | publication date | 1970-09-01 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Epidemic Shiga Bacillus Dysentery in Central America. I. Etiologic Investigations in Guatemala, 1969 | |
P478 | volume | 122 |
Q36957798 | An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine |
Q73312589 | An outbreak of Shiga bacillus dysentery in KwaZulu/Natal, South Africa |
Q45087869 | Antibiotic resistance of Shigella strains isolated in the Federal Republic of Germany 1989-1990. |
Q46639481 | Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): increasing frequency of multiple resistance |
Q33936849 | Antimicrobial resistance in the tropics |
Q43309801 | Batch process solar disinfection is an efficient means of disinfecting drinking water contaminated with Shigella dysenteriae type I. |
Q93192095 | Burden of laboratory-confirmed shigellosis infections in Guatemala 2007-2012: results from a population-based surveillance system |
Q36461093 | Characterization of an R-Plasmid Associated with Ampicillin Resistance in Shigella dysenteriae Type 1 Isolated from Epidemics |
Q40581944 | Cholera El Tor in Latin America, 1991-1993. |
Q36844719 | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road |
Q36194407 | Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. |
Q35754969 | Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens |
Q39498427 | Comparison of sucrose with glucose in oral therapy of infant diarrhoea |
Q37343213 | Diagnostic value of indirect hemagglutination in the seroepidemiology of Shigella infections |
Q28744352 | Dipstick test for rapid diagnosis of Shigella dysenteriae 1 in bacterial cultures and its potential use on stool samples |
Q33877398 | Dr. Kiyoshi Shiga: discoverer of the dysentery bacillus |
Q41812066 | Drug resistance and plasmid profile of shigellae in Taiwan |
Q36444089 | Enteric infections and the vaccines to counter them: future directions |
Q54292516 | Epidemic shiga dysentery in Central America. |
Q36504937 | Epidemiology of shigellosis in Teknaf, a coastal area of Bangladesh: a 10-year survey |
Q40481471 | Gender perceptions predict sex differences in growth patterns of indigenous Guatemalan infants and young children. |
Q33686643 | Genomic analysis of the emergence of 20th century epidemic dysentery. |
Q39306485 | Global phylogeography and evolutionary history of Shigella dysenteriae type 1. |
Q36505352 | High level resistance to trimethoprim, cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada--an update |
Q48818354 | INCAP studies of nutrition and infection |
Q37167794 | Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections |
Q39429450 | Immunomagnetic separation and PCR detection show Shigellae to be common faecal agents in children from urban marginal communities of Costa Rica |
Q34828010 | Importation of Shiga bacillus dysentery into California. Clinical and public health significance |
Q50688240 | Incidence of multiple antibiotic resistances in organisms isolated from cases of infantile diarrhoea in a Nigerian oral rehydration therapy clinic. |
Q55393967 | Isolation of Shigella species and their resistance patterns to a panel of fifteen antibiotics in mid and far western region of Nepal. |
Q54640033 | Letter: Ampicillin-resistant Shiga bacillus in Bangladesh. |
Q39388407 | Letter: Transfer of ampicillin resistance from Shigella dysenteriae type 1 to Escherichia coli |
Q35598035 | Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit |
Q35266183 | Magnitude of drug resistant shigellosis in Nepalese patients |
Q40691166 | Microbial development of drug resistance: mechanisms and clinical significance |
Q46693238 | Multi-gene amplification: simultaneous detection of three virulence genes in diarrhoeal stool |
Q36472443 | Occurrence of multiple antibiotic resistance and R plasmids in Enterobacteriaceae isolated from children in the Sudan |
Q36675006 | Oral rehydration and maintenance of children with rotavirus and bacterial diarrhoeas |
Q46799503 | Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers. |
Q30403500 | Plasmid analysis of Shigella dysenteriae type 1 isolates obtained from widely scattered geographical locations |
Q45230483 | Plasmid characterisation in the investigation of an epidemic caused by multiply resistant Shigella dysenteriae type 1 in Central Africa |
Q42148303 | Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa |
Q36505004 | Plasmid profile analysis and antimicrobial susceptibility patterns of Shigella isolates from Nigeria |
Q36504991 | Plasmid profiles of antibiotic-resistant Shigella dysenteriae types 2, 3, 4, 6 and 7 isolated in Ethiopia during 1976-85. |
Q42258091 | Plasmid-determined antibiotic resistance in Shigella flexneri isolated in England and Wales between 1974 and 1978 |
Q44235396 | Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. |
Q37339622 | Prevalence of Shigella serogroups and their antimicrobial resistance patterns in southern Trinidad |
Q40230921 | Quantitative microtiter cytotoxicity assay for Shigella toxin. |
Q33725239 | Randomized trial of high- and low-dose ampicillin therapy for treatment of severe dysentery due to Shigella dysenteriae type 1 |
Q93697809 | Science and non-science in psychiatry |
Q69254226 | Serum enterotoxin-neutralizing antibody in human shigellosis |
Q93754902 | Shiga bacillus dysentery complicated by bacteremia and disseminated intravascular coagulation |
Q30371964 | Shigella dysenteriae type 1 infections in US travellers to Mexico, 1988. |
Q42045506 | Shigella dysenteriae type 1--severe dysentery and sepsis with hematologic, hepatic and renal complications |
Q36258170 | Shigella species from Addis Ababa: frequency of isolation and in vitro drug sensitivity |
Q34019305 | Shigella: A Highly Virulent and Elusive Pathogen |
Q43325908 | Shigellosis in Mozambique: the 1993 outbreak rehabilitation--a follow-up study |
Q36448762 | Shigellosis in the south-western Cape of Good Hope 1968-85. |
Q47901479 | Spontaneous tandem amplification and deletion of the shiga toxin operon in Shigella dysenteriae 1. |
Q34000330 | Strategy for cross-protection among Shigella flexneri serotypes |
Q35651224 | The genome of Shigella dysenteriae strain Sd1617 comparison to representative strains in evaluating pathogenesis |
Q34069456 | The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. |
Q36506214 | The prevalence and genetics of resistance to commonly used antimicrobial agents in faecal Enterobacteriaceae from children in Bangladesh |
Q40853204 | The threat of multiresistant microorganisms |
Q33269861 | Using European travellers as an early alert to detect emerging pathogens in countries with limited laboratory resources |
Q35119483 | Virulence versus resistance |
Q36505152 | Waterborne transmission and the evolution of virulence among gastrointestinal bacteria |
Q68916401 | Widal-type serology using live antigen for diagnosis of Shigella flexneri dysentery |
Search more.